A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
第一作者:
Brendan P,Madden
第一单位:
Department of Cardiothoracic Medicine, Atkinson Morely Wing, St. George's Hospital, Blackshaw Road, Tooting, London SW17 0QT, UK. Brendan.madden@stgeorges.nhs.uk
作者:
医学主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);超声心动描记术(Echocardiography);运动试验(Exercise Test);女(雌)性(Female);人类(Humans);高血压, 肺性(Hypertension, Pulmonary);男(雄)性(Male);磷酸二酯酶抑制剂(Phosphodiesterase Inhibitors);哌嗪类(Piperazines);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);肺纤维化(Pulmonary Fibrosis);嘌呤类(Purines);砜类(Sulfones);治疗结果(Treatment Outcome);步行(Walking)
DOI
10.1016/j.vph.2006.01.013
PMID
16574495
发布时间
2015-11-19
- 浏览0
Vascular pharmacology
372-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



